CD Biosynsis offers expert Bacillus subtilis Genome Editing Services, utilizing state-of-the-art CRISPR-Cas9 and derivative technologies for highly efficient and precise genetic modification of this key industrial and model strain. Genetic manipulation of Bacillus subtilis is crucial for metabolic engineering, heterologous protein expression, and functional genomics. Our comprehensive services cover all editing needs, including: CRISPR-Cas9 Gene Editing, Efficient Gene Knockout, Precise Gene Knock-in, CRISPRi Gene Repression, and Precision Base Editing. We guarantee sequence fidelity and high positive clone rates to accelerate your microbial engineering projects.
Get a QuoteBacillus subtilis holds a central position in biotechnology, widely used for producing enzymes, antibiotics, and vitamins. Successful metabolic engineering and strain optimization rely on precise genetic manipulation. We utilize an optimized CRISPR-Cas9 system that overcomes common challenges in B. subtilis editing, such as low homologous recombination efficiency, ensuring high efficiency and minimal off-target effects. Our high-precision editing results prevent unwanted phenotypic changes and production declines, which is vital for the success of your research and industrial applications.
Utilizing our optimized CRISPR-Cas9 platform for rapid, site-specific, and highly efficient cleavage and editing of the Bacillus subtilis genome.
Stable and permanent inactivation of target genes via precise Gene Knockout techniques for loss-of-function studies and metabolic pathway interruption.
Offering Gene Knock-in to insert promoters, reporter genes, or large genetic fragments at specific loci for strain enhancement or heterologous expression.
Based on CRISPRi (CRISPR Interference) technology, we achieve reversible and highly efficient silencing or downregulation of target gene expression without altering the gene sequence.
Promoter Engineering
Custom design and optimization of promoter sequences to precisely regulate the expression level and timing of target genes, supporting complex industrial fermentation.
Utilizing Base Editing technology to achieve efficient, double-strand break-free single-base substitutions for resistance site mutation or specific amino acid replacement.
SNP/Point Mutation Introduction
Rapid introduction of SNPs (Single Nucleotide Polymorphisms) or Point Mutations into the Bacillus subtilis genome for directed evolution or mechanistic studies.
Our meticulous process ensures high success rates and rigorous quality control for every editing project.
Gene Design & Optimization
Vector Construction & Transformation
Screening, Purification & QC Verification
Delivery & Project Report
Confirm target gene locus and editing strategy (Knockout/Knock-in/Mutation) with the client.
Design and synthesize highly active, specific sgRNA and homology arms.
Optimize editing sequences to minimize off-target effects.
Construct the CRISPR editing vector containing Cas9 and sgRNA.
Deliver the editing tools into Bacillus subtilis cells using optimized protoplast transformation or electroporation methods.
Delivery of successful edited strains and control strains.
Provision of a comprehensive project report, sequencing data, and Certificate of Analysis (CoA).
High Success Rate CRISPR System
Our CRISPR-Cas9 platform is specifically optimized for B. subtilis, overcoming transformation and recombination hurdles to ensure high positive clone rates.
Comprehensive Editing Capabilities
From Gene Knockout to Base Editing, we offer full-range customization for single-base modification up to large fragment insertion.
Strict Sequencing Verification (QC)
All editing results are verified by Sanger Sequencing or NGS, providing detailed genotype analysis reports.
Support for Metabolic Engineering
Our techniques focus on metabolic pathway optimization and industrial strain modification, helping to enhance fermentation yield and efficiency.
"The precision of the knock-in edits we requested for our Bacillus subtilis strain was exceptional. The high positive clone rate saved us significant time in downstream screening."
Dr. Alex Rivas, Lab Director, Functional Genomics Institute
"We commissioned CD Biosynsis to support an intricate metabolic engineering project with multiple chromosomal targets. Their ability to produce high-quality work quickly was impressive. Their solutions were custom made to suit our needs, and they went above and beyond."
Dr. Raj Patel, Principal Investigator, University Molecular Biology Department
"Their CRISPRi repression service provided the tunable gene knockdown necessary for optimizing our fermentation pathway intermediates. The results were highly reproducible."
Ms. Sarah Jenkins, VP of Bioprocess Development, BioTech Company
"As a pharmaceutical company working to discover new production strains, we require accurate, trustworthy gene editing solutions. CD Biosynsis exceeded our expectations in providing strong, accurate CRISPR/Cas9 solutions for our preclinical research."
Dr. Clara Rodriguez, Chief Scientist, European Pharmaceutical R&D
What is the primary technology you use for B. subtilis gene editing?
We primarily use the optimized CRISPR-Cas9 system and its derivatives, such as CRISPRi for gene repression, and Base Editing for single-base substitution, catering to various editing requirements.
How is the success rate guaranteed for your Gene Knockout service?
We ensure a very high positive rate for Gene Knockout by optimizing sgRNA design and homology arm length, combined with high-efficiency transformation and screening. All results are confirmed via sequencing verification.
Can you insert large gene fragments using the Gene Knock-in service?
Yes, our Gene Knock-in methods are optimized to facilitate the precise integration of large genetic cassettes (e.g., biosynthetic gene clusters or multi-enzyme pathways) into the B. subtilis chromosome, supporting complex metabolic engineering projects.
How long does a typical B. subtilis genome editing project take?
The timeline depends on complexity (e.g., single knockout vs. multi-locus knock-in). A standard single gene knockout typically takes 6-8 weeks from design finalization to verified strain delivery. We provide a detailed timeline upon project assessment.
What quality control (QC) verification is included for the edited strain?
Our QC includes PCR amplification of the edited locus, followed by Sanger Sequencing across the entire edited region (including homology arms and integration site) to confirm sequence fidelity. NGS is used for complex projects like large libraries.
Can you perform multiplex editing (editing multiple genes simultaneously)?
Yes, we offer multiplex editing by designing and optimizing multiple sgRNAs within a single CRISPR system. This is often used for optimizing complex metabolic pathways or knocking out several genes required for pathway blocking.
What B. subtilis strains can you work with?
We routinely work with common lab and industrial strains like 168, PY79, and many proprietary strains. We can optimize the editing protocol for specific strains if necessary, following a preliminary feasibility assessment.
What deliverables do I receive upon project completion?
You will receive the final, verified edited B. subtilis strain (lyophilized or frozen stock), a detailed Certificate of Analysis (CoA), all raw and analyzed sequencing data, and a comprehensive Project Report detailing the methodology.
Do you offer a Precision Base Editing service for single point mutations?
Yes, our Precision Base Editing service allows for highly efficient A-to-G or C-to-T conversions in B. subtilis without creating a double-strand break, which is ideal for introducing precise point mutations or modifying regulatory regions.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.